Match each routine prenatal screening or evaluation milestone to its optimal gestational age window in an uncomplicated pregnancy, according to standard obstetric guidelines.
- 11 to 14 weeksNuchal translucency measurement and serum PAPP-A evaluation
- 18 to 22 weeksComprehensive fetal anatomic survey ultrasound
- 24 to 28 weeks50-g one-hour oral glucose challenge test
- 36 to 38 weeksUniversal vaginal-rectal culture for Group B Streptococcus
Cevap
The correct timeline aligns first-trimester aneuploidy screening (NT/PAPP-A) to 11-14 weeks, the anatomic survey ultrasound to 18-22 weeks, gestational diabetes screening (glucose challenge) to 24-28 weeks, and Group B Streptococcus culture to 36-38 weeks.
Each routine prenatal screening test relies on a specific physiological or evidence-based window. Early aneuploidy screening utilizes early developmental markers (11-14 weeks). Anatomic surveys require sufficient fetal size (18-22 weeks). Gestational diabetes screening targets the peak of placental hormone-induced insulin resistance (24-28 weeks). Finally, GBS screening is timed to ensure the culture result is valid (within 5 weeks) for an anticipated term delivery (36-38 weeks).
Adım Adım Çözüm
Anahtar Kavram
Routine Prenatal Care Timeline and Screening Milestones